Aditxt Inc ADTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:51 PM EDT
0.14quote price arrow up+0.00 (+1.33%)
Volume
58,674
Close
0.1431quote price arrow down-0.0131 (-8.3867%)
Volume
2,583,706
52 week range
0.12 - 3.95
Loading...
  • Open0.1515
  • Day High0.158
  • Day Low0.142
  • Prev Close0.1562
  • 52 Week High3.95
  • 52 Week High Date08/25/21
  • 52 Week Low0.12
  • 52 Week Low Date06/22/22

Key Stats

  • Market Cap6.40M
  • Shares Out44.73M
  • 10 Day Average Volume5.28M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-73.31

KEY STATS

  • Open0.1515
  • Day High0.158
  • Day Low0.142
  • Prev Close0.1562
  • 52 Week High3.95
  • 52 Week High Date08/25/21
  • 52 Week Low0.12
  • 52 Week Low Date06/22/22
  • Market Cap6.40M
  • Shares Out44.73M
  • 10 Day Average Volume5.28M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-73.31

RATIOS/PROFITABILITY

  • EPS (TTM)-1.91
  • P/E (TTM)-0.07
  • Fwd P/E (NTM)0.14
  • EBITDA (TTM)-41.452M
  • ROE (TTM)-572.32%
  • Revenue (TTM)320,000.00
  • Gross Margin (TTM)15.62%
  • Net Margin (TTM)-14,604.94%
  • Debt To Equity (MRQ)13.26%

EVENTS

  • Earnings Date08/12/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aditxt Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Aditxt, Inc., formerly Aditx Therapeutics, Inc., is a biotechnology company. The Company is developing technologies focused on improving the health of the immune system through immune mapping and reprogramming. The Company’s immune mapping technologies are designed to provide a personalized comprehensive profile of the immune system. The Company’s Apoptotic DNA Immunotherapy (ADi) technology has two categories, the AditxtReprogramming therapeutic program, which includes ADi...
Amro Albanna
Chairman of the Board, Chief Executive Officer
Corinne Pankovcin
President
Rowena Albanna
Chief Operating Officer
Thomas Farley
Chief Financial Officer
Address
737 N. Fifth Street, Suite 200
Richmond, VA
23219
United States